ArticleInternational urology and nephrology2025

Rituximab, tacrolimus, cyclophosphamide and cyclosporin in primary membranous nephropathy with nephrotic syndrome: comparison of safety profiles, effect on remission rate, 24-h urinary total protein, serum albumin, and serum creatinine levels using network meta-analysis.

Ni Cai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.